bone marrow transplantation in patients with thalassemia

Authors

اردشیر قوام زاده

a ghavamzadeh عیسی بایبوردی

i bayboordi محمد جهانی

ماندانا محی الدین

abstract

during april, 1991 and september, 1993, eighteen patients with major thalassemia admitted to shariati bmt center. seventeen patients were transplanted were from hla identical siblings and one from. his hla identical father. eleven of the donors were the known cases of minor thalassemia. the range of patients' age was within 3-10 years (with the average of 5 years and 11 months). among them, seven patients were male and eleven were female. as the other international bmt centers, we classified our patients into three classes. our criteria for this classification were hepatomegaly, ferretin, and liver fibrous 60% of our patients were put in class i and 40% in class ii. all of our patients revealed a gvhd (severe graft vs. host disease) three weeks post-bmt as pruritus, diarrhea, and skin erythema especially in hands and feet. two of the patients showed severe gvhd. one of the patients had chimerism after bmt. although one year after bmt has passed, the patients is still depended on blood transfusion. one patient, despite graft rejection, died nine months post-bmt another one died after +70 due to gvhd. during 2.5 years, the overall graft survival rate was 88% in our center

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Bone Marrow Transplantation in Thalassemia (Part 2)

During the last two decades conventional therapy has improved the prognosis of thalassemia. However, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. Bone marrow transplantation (BMT) can prevent or delay progression of the aforementioned complications. The importance of clinical research...

full text

Bone Marrow Transplantation in Thalassemia (Part 1)

During the last two decades conventional therapy has improved the prognosis of thalassemia. However, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. Bone marrow transplantation (BMT) can prevent or delay progression of the aforementioned complications. The importance of clinical research...

full text

Bone marrow transplantation in thalassemia.

Since 1983, 350 patients aged 1 to 19 years with beta-homozygous thalassemia were given infusions of HLA-identical marrow after high doses of busulphan and cyclophosphamide. Survival and event-free survival leveled off about 1 year after bone marrow transplantation at 82% and 75%, respectively. In 172 consecutive patients who were treated with our current regimen since June 1985, a multivariate...

full text

Bone Marrow Transplantation in Thalassemia ( Part 1 )

During the last two decades conventional therapy has improved the prognosis of thalassemia. However, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. Bone marrow transplantation (BMT) can prevent or delay progression of the aforementioned complications. The importance of clinical research...

full text

bone marrow transplantation in thalassemia (part 2)

during the last two decades conventional therapy has improved the prognosis of thalassemia. however, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. bone marrow transplantation (bmt) can prevent or delay progression of the aforementioned complications. the importance of clinical research...

full text

Bone marrow transplantation in adult thalassemia.

Early trials of allogeneic marrow transplantation for homozygous thalassemia were disappointing in patients older than 16, with four of six patients dying early of graft-versus-host disease-related complications, one patient dying at 9 months of infection due to graft failure, and one dying at 6 years of recurrent thalassemia. Three classes of risk could be identified in analyses of results of ...

full text

My Resources

Save resource for easier access later


Journal title:
مجله دانشکده پزشکی دانشگاه علوم پزشکی تهران

جلد ۵۱، شماره ۲، صفحات ۸-۱۲

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023